Cancer Diagnosis & Therapy Monitoring

We develop novel optical imaging devices and algorithms for early diagnosis and therapy optimization for oral, ovarian and lung cancers.

Characterization of Pre-cancer Lesions Using SFDI

Optical imaging has unique advantages compared to other imaging modalities, including simplicity, low-cost and small size.

Additionally, new developments in fluorescent molecular probes, especially “switchable” and “tumor-selective” probes have raised new directions in in vivo fluorescent molecular imaging. Since these probes fluoresce in the near-infrared (NIR) optical window, where optical absorption is very low so that light can penetrate deeply, fluorescence imaging has been successfully translated from a microscopy level to whole body small animal imaging and clinics.

Ovarian Cancer Detection and Drug Delivery

Under Construction.

Close Menu